Pharma & Biotech

Phibro Animal Health Corporation continues to demonstrate remarkable market performance, driven by exceptional fiscal results and strategic expansion within the...

Despite showcasing its industry-critical role at two major healthcare conferences this week, Certara's stock continues to trade at depressed levels....

Investor attention turns to Hutchmed (NASDAQ: HCM) this week as the biopharmaceutical company unveils significant clinical findings at the annual...

Biotechnology firm Ocugen has announced a fundamental restructuring of its operations, marking a decisive shift in corporate strategy. The company...

The investment community is holding its breath as aTyr Pharma shares enter a period of suspended animation. Market attention is...

The investment climate surrounding Caribou Biosciences is fraught with tension. As this biotechnology firm pursues groundbreaking medical advancements with its...

The decision to postpone a critical special shareholder meeting regarding its planned acquisition by XenoTherapeutics has triggered a significant sell-off...

Could one therapy transform an underfunded biotech into a market leader? TG Therapeutics is making a compelling case with its...

While numerous biotechnology firms maintain a singular focus on research, Gilead Sciences is executing a multi-pronged growth strategy. This approach...

Viking Therapeutics finds itself navigating significant market headwinds in the wake of recent clinical data presentations. The company's stock experienced...